Related Experiment Video
Updated: Jun 29, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Does Portal Hypertension Increase the Risk of Helicobacter pylori Infection and Pre-Malignant Gastric Lesions?
Rui Gaspar1, Pedro Cardoso1, Tiago Ribeiro1
1Gastroenterology and Hepatology, Unidade Local de Saúde de São João, Porto 4200, Portugal.
Insights
Portal hypertension in cirrhosis is linked to gastropathy, but not Helicobacter pylori infection or pre-malignant lesions. Spleen and liver stiffness measurements correlate with gastropathy, not H. pylori or precancerous changes.
Area of Science:
- Gastroenterology and Hepatology
- Diagnostic Imaging
- Oncology
Background:
- Portal hypertension is a critical prognostic factor in cirrhosis, increasing mortality and complications.
- Hepatic venous pressure gradient is the gold standard for diagnosis, with spleen stiffness emerging as a non-invasive tool.
- The relationship between portal hypertension, Helicobacter pylori infection, and pre-malignant gastric lesions remains underexplored.
Purpose of the Study:
- To investigate the association between portal hypertension, assessed by liver and spleen elastography, and Helicobacter pylori infection.
- To evaluate the correlation between elastography findings and pre-malignant gastric lesions in cirrhotic patients.
- To determine if spleen and liver stiffness measurements are linked to H. pylori or precancerous gastric changes.
Main Methods:
- An observational study included 155 cirrhotic patients from December 2020 to December 2022.
- All participants underwent upper endoscopy and liver/spleen elastography by a blinded operator.
- Histological analysis assessed H. pylori infection and pre-malignant gastric lesions (gastric atrophy, metaplasia).
Main Results:
- Liver stiffness median: 24.4 kPa; Spleen stiffness median: 49.1 kPa.
- Portal hypertensive gastropathy was present in 32.9% of patients.
- H. pylori infection (34.8%), gastric atrophy (35.5%), and gastric metaplasia (38.7%) were observed.
- Liver and spleen stiffness correlated with portal hypertensive gastropathy (p < 0.01).
- No association was found between stiffness measurements and H. pylori infection or pre-malignant lesions.
Conclusions:
- H. pylori infection and pre-malignant gastric lesions occur in nearly one-third of cirrhotic patients.
- These conditions are not associated with liver or spleen stiffness measurements.
- Liver and spleen stiffness measurements are significantly associated with portal hypertensive gastropathy in cirrhotic patients.
Abstract:
Background and Aims: The presence of portal hypertension in cirrhotic patients is a major prognostic factor associated with the development of severe complications and increased mortality. The gold standard for diagnosing portal hypertension is the hepatic venous pressure gradient. More recently, spleen stiffness has emerged as a new and non-invasive diagnostic tool, and has already been included in the last Baveno VII guidelines. The exact prevalence of Helicobacter pylori infection, pre-malignant lesions and their relation to portal hypertension have never been described. The aim of our study was to evaluate the relationship between the presence of portal hypertension assessed via liver and spleen elastography and Helicobacter pylori infection and pre-malignant gastric lesions. Methods: An observational study was conducted, including consecutive patients admitted from December 2020 to December 2022. All patients underwent upper endoscopy and were also subjected to liver and spleen elastography (using the new probe of 100 Hz) by the same blinded operator in a tertiary center. Results: We included 155 cirrhotic patients, with a mean age of 64.1 years (±8.8), and 81.3% were male. The most common etiology was alcoholic liver disease (72.9%). The median value of liver stiffness measurement was 24.4 kPa [3.1-75.0], and the spleen stiffness measurement was 49.1 kPa [12.8-100.0]. Akin to endoscopic findings, 50.3% presented esophageal varices, 5.2% gastric atrophy, 11.6% gastric metaplasia, and 32.9% portal hypertension gastropathy. Regarding histologic findings, we found that 34.8% presented H. pylori infection, 35.5% gastric atrophy (OLGA 1-58.2%) and 38.7% gastric metaplasia (OLGIM 1-63.3%). Liver stiffness and spleen stiffness measurements were associated with the presence of portal hypertensive gastropathy (p < 0.01), but not with H. pylori infection or pre-malignant gastric lesions. Conclusions: Although present in almost one third of cirrhotic patients, H. pylori infection and pre-malignant gastric lesions are not associated with liver stiffness and spleen stiffness measurements. On the other hand, we found an association between liver stiffness and spleen stiffness measurements and portal hypertensive gastropathy.
More Related Videos
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
10:44One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
Related Concept Videos
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy